This article walks UK investors through what AstraZeneca looks like today: the most recent verified financials, share price context,Dividendpolicy, the broad shape of the pipeline, and the risks that could shape the stock through the rest of 2026.
After the consumer healthBusinesswas demerged as Haleon, GSK pitched itself to investors as a more focused biopharma company with deeper exposure to fast-growing therapy areas. The 2025 prints provide some of the strongest evidence to date that this strategy is bearing fruit, particularly in …
Key Takeaways – May 2026
Key Takeaways for May 2026
Why Is LSE:SPI - Spire Healthcare Stock Trading Up 48% Today On May 14 2026?
Why Is LSE:OPTI - OptiBiotix Health Stock Up 14% Today On 14 May 2026?
Fusion Antibodies PLC(LSE:FAB) has moved lower today as investor sentiment weakens across small-cap biotechnology and life sciences companies. Early-stage biotech businesses remain highly sensitive to funding conditions, commercial progress, and broader risk appetite within healthcare markets. This cautious environment is weighing on LSE:FAB.
Allergy Therapeutics Plc(LSE:AGY) has moved lower today as investor sentiment weakens across biotechnology and specialty pharmaceutical companies. Small-cap healthcare businesses remain vulnerable to marketVolatility, regulatory uncertainty, and funding concerns. This cautious market environment is weighing on LSE:AGY.
Ondine Biomedical, Inc. is a Canadian life sciences company specializing in light-activated antimicrobial therapies, also known as photodisinfection technology. The company’s flagship product, Steriwave®, is designed to reduce harmful pathogens in the nasal passages without contributing to antimicrobial resistance (AMR). Ondine has increasingly attracted …
Poolbeg Pharma PLCis a clinical-stage biopharmaceutical company focused on developing innovative therapies for infectious diseases, cancer immunotherapy-related conditions, and metabolic disorders. The company has attracted growing investor interest due to its diversified pipeline, artificial intelligence-driven drug discovery platform, and advancement of POLB 001, its …